Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XEENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCVEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCVECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCVECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCVEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCVEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.31.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.31.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.31.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.31.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.31.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.31.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.50ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.50ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.50EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.50EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.78EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.78ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.78ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.78EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.78EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.8NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
GK.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
GK.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XENCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
XENCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XENNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XENNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
XENUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XENUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
XENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XENUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XENUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XENUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used